Melissa Martinez never shies away from a learning opportunity. So, when the Springfield office nurse met with RMANJ founding partner Dr. Paul Bergh last June, she decided she wanted to learn more about infertility. “I asked Dr. Bergh if he would send me journal articles I could use to teach myself even more,” said Martinez, […]
Recent research into embryo assessment techniques, including data presented at ESHRE this year [Mitochondrial DNA levels as a marker of embryo viability in IVF], suggest that mitochondrial DNA content in the embryo may be predictive of its ability to produce a live birth. However, these studies compared outcomes between patients, which is not how the […]
The human microbiome has been termed the “second human genome” and it appears every bit as complex. The microbiome in human reproduction impacts both the reproductive tract and gametogenesis. Recent data have furthered our understanding of the microbiome, the biofilms it creates, and its impact of health and disease in human reproduction. Listen to Dr. […]
In collaboration with a cutting-edge biotechnology company, Auxogyn, RMANJ’s patients recently had the unique opportunity to participate in a non-invasive study where they were able to watch their embryos grow! Since the Eeva Comprehensive Chromosome Screening (CCS) Study launched last year, the RMANJ Clinical Research team has helped recruit over 100 participants. The final stages […]
The Paradigm of Clinical IVF is Shifting: The Time to Incorporate Validated Technologies and an Enhanced Understanding of Physiology is Now
Seemingly each month the IVF literature provides dramatic new publications detailing advances in our understanding of the physiology of the IVF system and describing powerful new genomic and culture related tools which may be employed to improve clinical outcomes. As such, the long standing paradigm of controlled ovarian hyperstimulation, oocyte retrieval, in vitro culture, and embryo transfer within a single cycle may soon be obsolete.
Reproductive Medicine Associates of New Jersey (RMANJ) and RMA Genetics is pleased to announce that Dr. Nathan Treff is the recipient of Bonei Olam’s 2013 Scientific Achievement Award
Reproductive Medicine Associates of New Jersey (RMANJ) and RMA Genetics is pleased to announce that Dr. Nathan Treff is the recipient of Bonei Olam’s 2013 Scientific Achievement Award. The award recognizes Dr. Treff’s contributions to the Bonei Olam mission and his significant achievements in reproductive medicine. Bonei Olam is an international, non-profit organization dedicated to […]